Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386019462> ?p ?o ?g. }
- W4386019462 endingPage "1028" @default.
- W4386019462 startingPage "1028" @default.
- W4386019462 abstract "Prehospital transfer protocols are based on rapid access to reperfusion therapies for patients with ischemic stroke. The effect of different protocols among patients receiving a final diagnosis of intracerebral hemorrhage (ICH) is unknown.To determine the effect of direct transport to an endovascular treatment (EVT)-capable stroke center vs transport to the nearest local stroke center.This was a prespecified secondary analysis of RACECAT, a multicenter, population-based, cluster-randomized clinical trial conducted from March 2017 to June 2020 in Catalonia, Spain. Patients were evaluated by a blinded end point assessment. All consecutive patients suspected of experiencing a large vessel occlusion stroke (Rapid Arterial Occlusion Evaluation Scale [RACE] score in the field >4 on a scale of 0 to 9, with lower to higher stroke severity) with final diagnosis of ICH were included. A total of 1401 patients were enrolled in RACECAT with suspicion of large vessel occlusion stroke. The current analysis was conducted in October 2022.Direct transport to an EVT-capable stroke center (n = 137) or to the closest local stroke center (n = 165).The primary outcome was tested using cumulative ordinal logistic regression to estimate the common odds ratio (OR) and 95% CI of the shift analysis of disability at 90 days as assessed by the modified Rankin Scale (mRS) score (range, 0 [no symptoms] to 6 [death]) in the intention-to-treat population. Secondary outcomes, included 90-day mortality, death or severe functional dependency, early neurological deterioration, early mortality, ICH volume and enlargement, rate of neurosurgical treatment, rate of clinical complications during initial transport, and rate of adverse events until day 5.Of 1401 patients enrolled, 1099 were excluded from this analysis (32 rejected informed consent, 920 had ischemic stroke, 29 had transient ischemic attack, 12 had subarachnoid hemorrhage, and 106 had stroke mimic). Thus, 302 patients were included (204 [67.5%] men; mean [SD] age 71.7 [12.8] years; and median [IQR] RACE score, 7 [6-8]). For the primary outcome, direct transfer to an EVT-capable stroke center (mean [SD] mRS score, 4.93 [1.38]) resulted in worse functional outcome at 90 days compared with transfer to the nearest local stroke center (mean [SD] mRS score, 4.66 [1.39]; adjusted common OR, 0.63; 95% CI, 0.41-0.96). Direct transfer to an EVT-capable stroke center also suggested potentially higher 90-day mortality compared with transfer to the nearest local stroke center (67 of 137 [48.9%] vs 62 of 165 [37.6%]; adjusted hazard ratio, 1.40; 95% CI, 0.99-1.99). The rates of medical complications during the initial transfer (30 of 137 [22.6%] vs 9 of 165 patients [5.6%]; adjusted OR, 5.29; 95% CI, 2.38-11.73) and in-hospital pneumonia (49 of 137 patients [35.8%] vs 29 of 165 patients [17.6%]; OR, 2.61; 95% CI, 1.53-4.44) were higher in the EVT-capable stroke center group.In this secondary analysis of the RACECAT randomized clinical trial, bypassing the closest stroke center resulted in reduced chances of functional independence at 90 days for patients who received a final diagnosis of ICH.ClinicalTrials.gov Identifier: NCT02795962." @default.
- W4386019462 created "2023-08-22" @default.
- W4386019462 creator A5015199135 @default.
- W4386019462 creator A5015863703 @default.
- W4386019462 creator A5019216136 @default.
- W4386019462 creator A5019880814 @default.
- W4386019462 creator A5027673913 @default.
- W4386019462 creator A5030217777 @default.
- W4386019462 creator A5042605731 @default.
- W4386019462 creator A5042752892 @default.
- W4386019462 creator A5043035754 @default.
- W4386019462 creator A5043622096 @default.
- W4386019462 creator A5061178069 @default.
- W4386019462 creator A5061456960 @default.
- W4386019462 creator A5067525055 @default.
- W4386019462 creator A5070521364 @default.
- W4386019462 creator A5078791960 @default.
- W4386019462 creator A5078863380 @default.
- W4386019462 creator A5080112120 @default.
- W4386019462 creator A5082451290 @default.
- W4386019462 creator A5087529597 @default.
- W4386019462 creator A5088266396 @default.
- W4386019462 creator A5090957908 @default.
- W4386019462 date "2023-10-01" @default.
- W4386019462 modified "2023-10-18" @default.
- W4386019462 title "Effect of Bypassing the Closest Stroke Center in Patients with Intracerebral Hemorrhage" @default.
- W4386019462 cites W1963728879 @default.
- W4386019462 cites W1993019581 @default.
- W4386019462 cites W2009849279 @default.
- W4386019462 cites W2017797252 @default.
- W4386019462 cites W2035762435 @default.
- W4386019462 cites W2064728233 @default.
- W4386019462 cites W2075849746 @default.
- W4386019462 cites W2094585602 @default.
- W4386019462 cites W2115637271 @default.
- W4386019462 cites W2120778013 @default.
- W4386019462 cites W2123430282 @default.
- W4386019462 cites W2126733169 @default.
- W4386019462 cites W2135533213 @default.
- W4386019462 cites W2136587148 @default.
- W4386019462 cites W2152150377 @default.
- W4386019462 cites W2157158198 @default.
- W4386019462 cites W2168934316 @default.
- W4386019462 cites W2268966914 @default.
- W4386019462 cites W2277258071 @default.
- W4386019462 cites W2526978419 @default.
- W4386019462 cites W2530373868 @default.
- W4386019462 cites W2785716478 @default.
- W4386019462 cites W2794182007 @default.
- W4386019462 cites W2888165333 @default.
- W4386019462 cites W2906253391 @default.
- W4386019462 cites W2914368780 @default.
- W4386019462 cites W2948012312 @default.
- W4386019462 cites W2956456196 @default.
- W4386019462 cites W2971647665 @default.
- W4386019462 cites W3035859669 @default.
- W4386019462 cites W3093284848 @default.
- W4386019462 cites W3107750320 @default.
- W4386019462 cites W3119944003 @default.
- W4386019462 cites W3128713285 @default.
- W4386019462 cites W3133742331 @default.
- W4386019462 cites W3135003982 @default.
- W4386019462 cites W3173237936 @default.
- W4386019462 cites W3198046686 @default.
- W4386019462 cites W4205473558 @default.
- W4386019462 cites W4229016502 @default.
- W4386019462 cites W4253504556 @default.
- W4386019462 cites W4307571138 @default.
- W4386019462 doi "https://doi.org/10.1001/jamaneurol.2023.2754" @default.
- W4386019462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37603325" @default.
- W4386019462 hasPublicationYear "2023" @default.
- W4386019462 type Work @default.
- W4386019462 citedByCount "4" @default.
- W4386019462 countsByYear W43860194622023 @default.
- W4386019462 crossrefType "journal-article" @default.
- W4386019462 hasAuthorship W4386019462A5015199135 @default.
- W4386019462 hasAuthorship W4386019462A5015863703 @default.
- W4386019462 hasAuthorship W4386019462A5019216136 @default.
- W4386019462 hasAuthorship W4386019462A5019880814 @default.
- W4386019462 hasAuthorship W4386019462A5027673913 @default.
- W4386019462 hasAuthorship W4386019462A5030217777 @default.
- W4386019462 hasAuthorship W4386019462A5042605731 @default.
- W4386019462 hasAuthorship W4386019462A5042752892 @default.
- W4386019462 hasAuthorship W4386019462A5043035754 @default.
- W4386019462 hasAuthorship W4386019462A5043622096 @default.
- W4386019462 hasAuthorship W4386019462A5061178069 @default.
- W4386019462 hasAuthorship W4386019462A5061456960 @default.
- W4386019462 hasAuthorship W4386019462A5067525055 @default.
- W4386019462 hasAuthorship W4386019462A5070521364 @default.
- W4386019462 hasAuthorship W4386019462A5078791960 @default.
- W4386019462 hasAuthorship W4386019462A5078863380 @default.
- W4386019462 hasAuthorship W4386019462A5080112120 @default.
- W4386019462 hasAuthorship W4386019462A5082451290 @default.
- W4386019462 hasAuthorship W4386019462A5087529597 @default.
- W4386019462 hasAuthorship W4386019462A5088266396 @default.
- W4386019462 hasAuthorship W4386019462A5090957908 @default.
- W4386019462 hasConcept C126322002 @default.
- W4386019462 hasConcept C127413603 @default.